In the final days of the Biden-Harris Administration, the U.S. Department of Health and Human Services (HHS) last week ...

As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people w ...

As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...

Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country healthier and ...

Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...